C. R. Bard, Inc. was an American multinational developer, manufacturer, and marketer of medical technologies in the fields of vascular, urology, oncology, and surgical specialties. Bard was founded in 1907 by Charles Russell Bard and was acquired by Becton, Dickinson and Company (BD) in December 2017 for approximately $24 billion.

Endovascular Engineering is a medical-device company developing minimally invasive thrombectomy technology for the removal of blood clots. Its lead product, the Helo PE Thrombectomy System, targets pulmonary embolism, pairing a small catheter profile with large-bore clot engagement via a self-expanding funnel and dual-action high-speed agitation…